Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Rocket's PRV Goes for $180M; Oruka Targets $500M Offering
New Jersey‑based Rocket Pharmaceuticals sold its pediatric‑disease priority‑review voucher for $180 million, setting a near‑record price for such assets. The cash infusion strengthens Rocket’s balance sheet as it advances late‑stage gene‑therapy candidates. Meanwhile, biotech firm Oruka Therapeutics announced plans to raise approximately $500 million through a public offering to fund its gene‑editing pipeline. Both moves underscore the growing reliance on alternative financing mechanisms in the biotech sector.
A Collective Cognitive Dissonance
The author challenges the common refrain that every Epic electronic‑health‑record (EHR) instance is fundamentally different, arguing that the real source of variation lies in the hospitals’ unique workflows, staffing, and local policies rather than the software itself. While customization is...
Humanizing the Ultimate Balancing Act
The article argues that aligning radiology, IT, finance, and operations in healthcare requires treating stakeholders as humans, not adversaries. It highlights that each function has non‑negotiable priorities—quality and safety for radiology, security for IT, margin for finance, and throughput for...
Integrating a Waste Walk Into Technology Adoption: A Primer
Medical imaging leaders often adopt new scanners, AI tools or PACS without fully understanding the underlying workflow problems, leading to under‑utilization and missed KPI targets. A waste walk—rooted in Lean methodology—offers a low‑cost, observational approach that maps the entire value...
Availity Introduces Availity Extend to Secure Healthcare Automation at Scale
Availity, the nation’s largest healthcare network, launched Availity Extend, a platform that lets payers, providers, and tech partners build automation and AI directly on its network. The solution leverages Availity’s existing connectivity and security framework, enabling workflows to run with live...
Natural Disasters Can Cause Another Crisis for Those Recovering From Opioid Addiction
Natural disasters such as Hurricane Helene are exposing a critical weakness in the U.S. opioid‑recovery system, leaving patients without essential medication like Suboxone. The storm forced patients to travel out of state and confront pharmacy shortages, illustrating how climate‑related emergencies...
Science in Space
NASA astronaut Chris Williams and ESA astronaut Sophie Adenot conducted the DNA Nano Therapeutics‑3 experiment in the Kibo laboratory’s Life Science Glovebox aboard the International Space Station. The study explores DNA‑inspired assembly techniques to fabricate nanostructured cancer therapies such as chemotherapy and...
Clinical Utility of the AITIS Model for Test-Free Identification of Sarcopenia in Patients with Stage IV–V Non-Dialysis-Dependent Chronic Kidney Disease
The study validates the Artificial Intelligence to Identify Sarcopenia (AITIS) model as a test‑free screening tool for sarcopenia in 236 patients with stage IV–V non‑dialysis chronic kidney disease. Using only age, sex, height, weight and 20 self‑reported functional items, AITIS achieved...
Association Between the Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and Carotid Plaque: A Retrospective Cohort Study
A retrospective cohort of 5,985 Chinese adults followed for an average of 2.2 years found that a higher non‑HDL‑C to HDL‑C ratio (NHHR) independently predicts incident carotid plaque. Participants in the top NHHR quartile experienced a 64% greater hazard of...
Prognostic Value of the Triglyceride-Glucose (TyG) Index for Renal Function Progression in Patients with CKD Stages 3–4
A multicenter retrospective cohort of 53,607 Chinese patients with chronic kidney disease (CKD) stages 3‑4 found the triglyceride‑glucose (TyG) index to be an independent predictor of renal function progression. Each 1‑unit increase in TyG was linked to a 10% higher hazard,...
Early Combined Parenteral and Enteral Nutrition Support for Patients over 80 Years Old with Non-Operative Intestinal Obstruction
A retrospective study of 191 patients over 80 with non‑operative intestinal obstruction compared early combined parenteral and enteral nutrition (ECPEN) to delayed combined nutrition (DCPEN). After 1:1 propensity score matching, 79 pairs showed that ECPEN led to shorter total parenteral...
Development of an Intelligent Food Nutrition Recognition and Nutrient Intake Assessment System in Hospital Settings
Researchers at Peking University People's Hospital created an AI‑driven food nutrition recognition system for therapeutic hospital meals. The platform combines RGB‑D imaging, the Segment Anything Model for segmentation, and a SE_ResNet50_vd classifier, achieving 99.2% accuracy in food type identification. Volume...
BeOne Medicines Licenses Trispecific Antibody Targeting PD-1, CTLA-4 and VEGF
BeOne Medicines, the rebranded former BeiGene, announced a licensing and option agreement to acquire a trispecific antibody that simultaneously targets PD‑1, CTLA‑4, and VEGF. The experimental biologic originates from a Chinese biotech and is positioned for development in solid‑tumor indications....
Economic Deprivation Led to Fewer Days at Home After Hip Fracture
A JAMA Network Open study of 52,012 Medicare hip‑fracture patients found that those living in the most economically deprived ZIP codes spent 23 fewer days at home during the year after surgery compared with peers in affluent areas. Mortality rose...
Med Ad Views Episode 07: Med Ad News 2026 Marketer on the Rise Recipient Dipa Sapre
Dipa Sapre, director of obesity HCP strategy at Novo Nordisk, was honored with the 2026 Marketer on the Rise Manny Award. In a Med Ad Views podcast, she discussed her career path across major pharma firms, the award‑winning obesity launch, and...
Empassion, Karoo Health Partner on Cardiac-to-Hospice Transitions
Empassion Health and Karoo Health announced a strategic partnership to smooth the transition from cardiac management to palliative and hospice care. The collaboration addresses the “gap” where patients with advanced heart disease are not yet eligible for hospice but traditional...
Superior Health Holdings Acquires Compassion Homecare and Sans Bois Hospice, Expanding Into Oklahoma
Superior Health Holdings, backed by Renovus Capital Partners, announced the acquisition of Chant Healthcare, the operator of Compassion Home Care and Sans Bois Hospice in southeastern Oklahoma. The deal gives Superior an immediate footprint across 11 counties, adding home health, hospice,...
AACR 2026: Combo Therapies by Moderna, Marengo Show Promise in Skin, Breast Cancer
Combination regimens dominated AACR 2026, with biotech firms showcasing new cocktail data across multiple tumor types. Marengo Therapeutics reported that its dual‑T‑cell agonist invikafusp alfa combined with Gilead’s ADC Trodelvy produced complete or partial responses in 40% of heavily pretreated...
Provider Data Management - A Niche but Important Problem | Out-Of-Pocket
CertifyOS tackles the chronic problem of inaccurate provider directories by aggregating data from rosters, CAQH, NPPES, state boards and the providers themselves into a unified, AI‑enhanced golden record. The platform normalizes disparate feeds, tracks changes with audit logs, and offers...
KLAS Finds Provider-Payer Collaborations Focused on Value-Based Care Workflows
KLAS’s 2026 Points of Light report shows that nearly 80% of award‑winning provider‑payer collaborations now target value‑based care workflows, up from 48% in 2025. The shift signals that basic interoperability has become a baseline, with success measured by financial and...
Sensitive Data as Venn Diagram
Healthcare data is split into "Normal" (non‑sensitive) and "Restricted" (sensitive) categories. Sensitive records receive specific sensitivity codes in the FHIR Resource.meta.security tag, creating a Venn diagram of overlapping topics such as Sexual Health, Mental Health, and Substance Use. The tags...
Microplastics Found in Most Human Brains, Concentrated Near Tumors
Microplastics and nanoplastics have been detected in nearly all human brain samples, including healthy tissue, with higher concentrations observed near tumors, raising new questions about their potential impact on brain health. microplastics
Google Exec Argues Safer LLMs, Not Bans, Aid Mental Health
Google executive defends potential of LLMs for mental health. “It can seem sometimes like shutting something down is a way of preventing harm,” Megan Jones Bell told STAT. “We believe that making our product experience safer and more helpful and...
Executing Biologics Technology Transfer Through Integrated Operating Models
The article advocates replacing the traditional sequential biologics tech‑transfer model with an integrated operating model that colocates development, manufacturing, MSAT and quality teams. By running small‑scale experiments and large‑scale runs concurrently, organizations can observe scale‑dependent effects in real time and...
Turn on, Tune in, Cash Out … The US Right Used to Fear Psychedelics. Now It Wants to Sell Them...
President Donald Trump, flanked by RFK Jr and podcaster Joe Rogan, signed an executive order on April 18 to accelerate federal approval of psychedelic‑based medicines, with a particular focus on ibogaine. The move marks a dramatic reversal from the 1960s, when the U.S....
Per‑Booking Pivot Saved Zocdoc’s Healthcare Apprenticeship Model
New Lifers episode with @oliver_kharraz, CEO of @Zocdoc, on why healthcare is a "lifelong apprenticeship" and how they survived a near-death business model pivot. We discuss: * Why early digital schedules failed because office managers were still blocking time with physical...
PurIST Classifier Validated for Tailored Pancreatic Cancer Therapy
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection [PurIST @TempusAI] in Pancreatic Ductal Adenocarcinoma [Sep 4, 2025] @stephwen et al. @JCOPO_ASCO https://t.co/R24DErvaB4 #pancsm #PrecisionMedicine https://t.co/KNJHtWovqT
AI Builders Summit: Healthcare Boston 2026
The AI Builders Summit – Healthcare edition will convene in Boston in 2026, gathering AI startups, established tech giants, investors, and healthcare providers. Organized by a coalition focused on edge‑AI, the event aims to accelerate machine‑intelligence solutions that process clinical...
Biliary Cancer Subtypes Show Distinct Immune Signatures
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO https://t.co/IN6UsL5jvN #hpbcsm #PrecisionMedicine https://t.co/p3BzJ82oxA
BRAF Class II/III Mutations Represent Unmet Clinical Need
Real-world clinical genomic analysis of Pts w/ BRAF mutated cancers identifies BRAF class II & III as a population of unmet medical need [3/7/22] Severson etal #ESMO2240P @TempusAI https://t.co/s5PEBEczlv @Annals_Oncology DOI: https://t.co/c3wxWyUuX0 #PrecisionMedicine #caxtx
Lawsuit Accuses Former N.C. EMT of Taking Photos of Dying Patient
A North Carolina lawsuit filed on April 23 alleges former Onslow County EMT Megan Jenkins photographed a critically injured patient on Aug. 25, 2025, and later shared the images. The complaint claims the county ignored protocols by not securing Jenkins’ phone or investigating...
ASCO Endorses Somatic Genomic Testing for Advanced Cancers
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: @ASCO Provisional Clinical Opinion [Feb 17, 2022] @CDebyaniPhD et al. @JCO_ASCO https://t.co/hfHUBS3Unx #PrecisionMedicine https://t.co/GwYOMRD1hh
BRAFV600E‑mutated Pediatric Gliofibroma Shows Fleeting Therapy Response
Rare Pediatric Invasive Gliofibroma Has BRAFV600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution [Mar 27, 2019] @KanevaMD et al. @JCOPO_ASCO https://t.co/oNbfrK7EZr #PrecisionMedicine #btsm https://t.co/V7k9vEiqKm
UnitedHealth’s Next Big Business Line? It Could Be AI Tools and Services
UnitedHealth Group is pouring roughly $1.5 billion into artificial‑intelligence initiatives this year, with a third earmarked for commercial software and services. Its Optum Insight unit already offers products such as Optum Real, which handles half‑billion transactions and aims for 2.5 billion by...
KRASG12C Mutations Linked to Distinct Immuno‑oncology Biomarkers
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers [Mar 23, 2022] @SalemGIOncDoc et al. @JCOPO_ASCO https://t.co/iehC82lyA4 #ImmunoOnc #PrecisionMedicine @TempusAI https://t.co/wZzfdnBoXU
Comprehensive Genomic Panel Broadens Community Oncology Treatment Options
Unique Features of a Comprehensive Genomic Profiling Panel: Expanding Treatment Options in a Value-Based Community Oncology Network [Mar 9, 2026] La Porte et al. @DrEzraCohen @JCOPO_ASCO https://t.co/tDi3kbxdvX #PrecisionMedicine #hemeonc @TempusAI https://t.co/6QKo7c3oH2
Drug Pricing, PBM Reform, and the 2026 Midterms: What You Need to Know
Analysts at Avalere Health’s AXS26 summit warned that the 2026 midterm elections will reshape drug pricing and PBM practices. Recent FTC settlements require Express Scripts, CVS Caremark and Optum Rx to end spread pricing and unlink compensation from rebates, while...
FDA Accuses Amgen of Data Manipulation; Erasca Falls
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results https://t.co/UbftjXwEwa $AMGN $ERAS - 53% $RCKT $JANX
Hospital CEOs Flaunt Lobbying Clout in Congressional Testimony
Hospital CEOs are currently testifying in front on Congress. @ahahospitals just held its annual meeting, and @_daniel_payne caught this extremely candid quote from Chuck Schumer showing just how much lobbying power hospitals have. https://t.co/suwZZjZePb https://t.co/IHVq3JrVEF
Rape, Sexual Assault and Long-Term Chronic Health Issues – Our New Study
New research using a large Danish cohort shows sexual assault dramatically raises the risk of chronic physical illnesses. Survivors are 69% more likely to report persistent somatic symptoms and six times more likely to develop widespread functional disorders such as...
AI Reads Retinal Images to Screen Multiple Diseases
What superhuman vision can detect from the retinal photo, which human eyes cannot, is stunning. A new foundation AI model screening for diabetes hypertension, hyperlipidemia, gout, osteoporosis, and thyroid disease @NatureMedicine https://t.co/GhKvUqz4Vy https://t.co/iKcXCbLceu
NIH Could Fund Groundbreaking Research with $2 B Annually
What could the NIH do with an extra $2 billion dollars a year from publisher fees?
Digitizing Medical Policy Alone Will Not Automate Prior Authorization at Scale
The CMS Interoperability & Prior Authorization rule now obliges health plans to digitize medical policies and expose them via FHIR APIs, but merely putting policies online hasn’t accelerated prior‑authorization turnaround. Availity’s EVP Matt Cunningham argues that true automation requires translating...
Probiotic Candidate Shows Potential to Suppress UTIs
Researchers reported that the probiotic strain Limosilactobacillus reuteri 3613‑1, which produces the antimicrobial compound reuterin, can inhibit key urinary and vaginal pathogens. In a randomized, double‑blind, placebo‑controlled trial of 130 healthy women taking the probiotic daily for 24 weeks, the...
FDA Approves Breztri for Patients 12 Years and Older with Asthma
The FDA has approved Breztri Aerosphere, a single‑inhaler triple‑combination of budesonide, glycopyrrolate, and formoterol, for maintenance treatment of asthma in patients aged 12 and older. This marks the first U.S. approval of a triple therapy that adds a long‑acting muscarinic...
As Health Costs Hit Record Highs, Brokers Face a Structural Test
Health insurance premiums surged to their highest level in more than a decade, pushing employers to reevaluate benefit strategies. Over 60% of firms are now actively shopping carriers or pharmacy benefit managers, and nearly half are exploring level‑funded, ICHRA or...
Global Expert Panel Reaches Consensus on Six Core Dimensions of Positive Mental Health
A panel of 122 leading scholars from 26 countries used a Delphi process to agree on six core dimensions of positive mental health—meaning and purpose, life satisfaction, self‑acceptance, connection, autonomy and happiness—each receiving over 90% support. The consensus aims to...
Daily Multivitamin Slows Biological Aging Up to Five Months, Study Finds
Researchers led by Howard Sesso published a peer‑reviewed trial showing that a daily Centrum Silver‑type multivitamin slowed two epigenetic aging clocks by 2.7–5.1 months over two years. The finding, based on 958 participants from the COSMOS study, marks the first...
Improving Health Literacy Requires Dual Efforts
Poor health literacy, especially among older adults, remains widespread, prompting federal action. The Office of Disease Prevention and Health Promotion’s National Action Plan and the CDC’s health‑literacy toolkit outline clear‑communication principles for providers and actionable guidance for patients. Experts recommend...
Updated: AbbVie Flirts with Popular Pan-RAS Field in up to $1.45B Option to Acquire Kestrel
AbbVie has signed a deal giving it an option to acquire Kestrel Therapeutics for up to $1.45 billion, targeting Kestrel’s pan‑RAS inhibitor platform. The agreement includes an upfront payment and milestone‑based earn‑outs tied to regulatory and commercial milestones. Kestrel’s lead candidate,...